Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study

por Jacobsen, Paula L., Harper, Linda, Chrones, Lambros, Chan, Serena, Mahableshwarkar, Atul R.
Publicado 2015